Lanzkron S - Search Results

1

COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study.

Anderson AR, Strouse JJ, Manwani D, Brandow AM, Vichinsky E, Campbell A, Leavey PJ, Nero A, Ibrahim IF, Field JJ, Baer A, Soto-Calderon H, Vincent L, Zhao Y, Santos JJS, Hensley SE, Mortier N, Lanzkron S, Neuberg D, Abrams CS. Anderson AR, et al. Among authors: lanzkron s. Blood Adv. 2024 Sep 10;8(17):4549-4553. doi: 10.1182/bloodadvances.2024013878. Blood Adv. 2024. PMID: 38991137 Free PMC article.

2

Hydroxyurea for the treatment of sickle cell disease.

Segal JB, Strouse JJ, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S. Segal JB, et al. Among authors: lanzkron s. Evid Rep Technol Assess (Full Rep). 2008 Mar;(165):1-95. Evid Rep Technol Assess (Full Rep). 2008. PMID: 18457478 Free PMC article. Review.

3

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB. Lanzkron S, et al. Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5. Ann Intern Med. 2008. PMID: 18458272 Free PMC article. Review.

4

Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.

Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB. Strouse JJ, et al. Among authors: lanzkron s. Pediatrics. 2008 Dec;122(6):1332-42. doi: 10.1542/peds.2008-0441. Pediatrics. 2008. PMID: 19047254 Review.

5

The excess burden of stroke in hospitalized adults with sickle cell disease.

Strouse JJ, Jordan LC, Lanzkron S, Casella JF. Strouse JJ, et al. Among authors: lanzkron s. Am J Hematol. 2009 Sep;84(9):548-52. doi: 10.1002/ajh.21476. Am J Hematol. 2009. PMID: 19623672 Free PMC article.

6

A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease.

Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB. Haywood C Jr, et al. Among authors: lanzkron s. J Natl Med Assoc. 2009 Oct;101(10):1022-33. doi: 10.1016/s0027-9684(15)31069-5. J Natl Med Assoc. 2009. PMID: 19860302 Review.

7

The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Strouse JJ, Lanzkron S, Urrutia V. Strouse JJ, et al. Among authors: lanzkron s. Expert Rev Hematol. 2011 Dec;4(6):597-606. doi: 10.1586/ehm.11.61. Expert Rev Hematol. 2011. PMID: 22077524 Free PMC article. Review.

8

Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.

Razdan S, Strouse JJ, Naik R, Lanzkron S, Urrutia V, Resar JR, Resar LM. Razdan S, et al. Among authors: lanzkron s. Case Rep Hematol. 2013;2013:516705. doi: 10.1155/2013/516705. Epub 2013 Jul 16. Case Rep Hematol. 2013. PMID: 23956892 Free PMC article.

9

Attitudes toward clinical trials among patients with sickle cell disease.

Haywood C Jr, Lanzkron S, Diener-West M, Haythornthwaite J, Strouse JJ, Bediako S, Onojobi G, Beach MC; IMPORT Investigators. Haywood C Jr, et al. Among authors: lanzkron s. Clin Trials. 2014 Jun;11(3):275-283. doi: 10.1177/1740774513519876. Clin Trials. 2014. PMID: 24532686 Free PMC article.

10

Quality improvement process in a sickle cell infusion center.

Whiteman LN, Lanzkron S, Stewart RW, Haywood C Jr, Strouse JJ, Feldman L. Whiteman LN, et al. Among authors: lanzkron s. Am J Med. 2015 May;128(5):541-4. doi: 10.1016/j.amjmed.2014.11.020. Epub 2014 Dec 9. Am J Med. 2015. PMID: 25498167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters